Cazals Manzo Pichot Saint Quentin also advised the sellers. L-GAM was advised by Shearman & Sterling, while BPI was advised by BDGS Associés and exiting fund Cathay Capital by De Pardieu Broccas MAffei.
Biose Industrie is a world leader in the development and production of live biotherapeutic products (LBPs). Founded in 1951 and taken over in 2007 by the Desjonsquères family, Biose industrie has experienced growth since 2017 in line with the evolution of a rapidly expanding market, supporting biotechs and pharmaceutical companies investing to bring out a new category of microbiotic drugs.
In acquiring joint control of the firm, L-GAM and the French State through the French Tech Souveraineté will support the group in a new phase of its development.
On completion of the transaction, which remains subject to all applicable regulatory authorisations, French Tech Souveraineté and L-GAM will become shareholders alongside Adrien Nivoliez, the future President of Biose Industrie, other Biose managers, the Fonds Souverain Auvergne-Rhône-Alpes (managed by Siparex) and the Desjonquères family.
The Rossi Bordes & Associés team was led by Maître France Portmann, co-head of the firm’s corporate law department, with the assistance of associate Pauline Thuet.
